Two Sigma Advisers’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.33M | Buy |
|
|||||
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $536K | Buy |
|
|||||
|
2024
Q4 | $313K | Buy |
|
|||||
|
2024
Q3 | $90.5K | Sell |
|
|||||
|
2024
Q2 | $255K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $106K | Sell |
|
|||||
|
2023
Q2 | $1.83M | Buy |
|
|||||
|
2023
Q1 | $1.63M | Sell |
|
|||||
|
2022
Q4 | $904K | Sell |
|
|||||
|
2022
Q3 | $1.48M | Sell |
|
|||||
|
2022
Q2 | $1.56M | Sell |
|
|||||
|
2022
Q1 | $3.39M | Sell |
|
|||||
|
2021
Q4 | $5.51M | Sell |
|
|||||
|
2021
Q3 | $10.8M | Sell |
|
|||||
|
2021
Q2 | $16.8M | Sell |
|
|||||
|
2021
Q1 | $20.1M | Buy |
|
|||||
|
2020
Q4 | $22M | Buy |
|
|||||
|
2020
Q3 | $2.47M | Buy |
|
|||||
|
2020
Q2 | $282K | Buy |
|